poof, 200K more premarket shorts were added to the count today. They'll rotate this all the way down to any support which presently sits at $3.20 or the 200DMA. SP sliced through 20 & 50 SMA like a falling knife.
yeah today they dropped SP to $3.62
5 days ago they were trading it at $4.44
14 months ago they were trading it at $5.40
The long term trend is DOWN
you only see what you want to which has been totally wrong
Looking fwd to meeting your daughters Padded bra & Tinted hair. Heard you really did a number on them Crazy horse? Last time I saw them they were working the corner on a roundabout in London.
charts don't lie people do. Like the 9 that belonged to the hedge fund shorting this down to the abyss again.
Jokao and Joanie and his merry band of pumpers. No where to be found. Despicable.
I wasn't 'pleasantly surprised' with earnings where you?
then there's that summer road kill barbeque held in the Menlow Office Parking lot. Hear they are roasting a few long term shareholders this year. Otta cost a few mil.
please GERN enough with all the gift giving...I have no room left. 18% giveback. Oh life as a GERN long has been all so bliss. Buttercups and rainbows. Which way to the asylum?
Every tick? Smiggly this has been a tick infestation. Down 70 cents now in 7 days, even God took a break on the 7th.
Scarlet stated as per the last presentation that the $35 mil was already added as total cash in the previous quarter. Jockao with his 'deceptive pumping' lead anyone who would listen astray believing otherwise. The $163 includes it.
Mr Magoo the judge dismissed half the class action suit exonerating GERN's management in not over promoting the drug IMET. He went on to advise the plaintiff if they were to pursue the case to perhaps focus only on the toxicity issues and whether GERN's management adequately informed shareholders of potential liver issues. Without trying this case further on a message board, my sense is that management justifiably thought the liver enzyme elevations had been adequately been dealt with in the trial by tweaking dosing. Had the FDA disagreed the hold would still be in place. The second part of this case has less to stand on based on the fact the complete hold was lifted last year. No company can predict the FDA's decision wrt their drugs approval...all come with disclosed risk. The liver issues were in fact overcome as later the FDA acknowledged by lifting their previous hold.
you forgot to subtract the $6mil worth of bonuses for all the gift giving our CEO has given us shareholders over the past 14 months. Just feel Gern's love.
zapping is still recommended on flies